Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | PRKCA | P17252 | 6/20 | 0.40 |
| ▸ | PRKCE | Q02156 | 4/20 | 0.40 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.40 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.40 |
| ▸ | DGKA | P23743 | 1/20 | 0.37 |
| ▸ | AKT1 | P31749 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20328970 | 1.00 | LMNA (0.42) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL25902806 | 0.90 | LMNA (0.55) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL25902771 | 0.90 | LMNA (0.55) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL19862069 | 0.87 | LMNA (0.53) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL19862076 | 0.87 | LMNA (0.53) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL25355688 | 0.84 | KDM4E (0.57) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL18632798 | 0.84 | KDM4E (0.57) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL18632826 | 0.84 | KDM4E (0.57) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL18623390 | 0.83 | LMNA (0.52) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL18623418 | 0.83 | LMNA (0.52) | LMNAKDM4EDUSP3MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230232872-A1 | COMPOUNDS AND FORMULATIONS FOR PROTECTIVE COATINGS | APEEL TECHNOLOGY, INC. | 2023-07-27 | — | — | US | disclosed |
| US-11641865-B2 | Compounds and formulations for protective coatings | APEEL TECHNOLOGY, INC. (US) | 2023-05-09 | — | — | US | disclosed |
| US-20180179401-A1 | Precursor Compounds for Molecular Coatings | APEEL TECHNOLOGY, INC. | 2018-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180179401-A1 | Precursor Compounds for Molecular Coatings | H1-10, CD209, PNISR | LMNA 1389/4885KDM4E 1378/4885DUSP3 3674/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.